Method for the production of selegiline hydrochloride

The present invention relates to a new method for preparing selegiline hydrochloride, particularly in the form of its (R)-(-)-enantiomer. Selegiline hydrochloride is a highly potent antiparkinsonic agent with low toxicity. The method of the invention consists in that 2-methylamino-1-phenylpropane is...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FERENC, MILAN, RNDR, KREPELKA, JIRI., CSC, KVAPIL, LUBOMIR, RNDR, POSPISIL, JOSEF, HRBATA, JIRI, PHMR DR, HAJICEK, JOSEF. CSC, PIHERA, PAVEL, BRUNOVA, BOHUMILA
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a new method for preparing selegiline hydrochloride, particularly in the form of its (R)-(-)-enantiomer. Selegiline hydrochloride is a highly potent antiparkinsonic agent with low toxicity. The method of the invention consists in that 2-methylamino-1-phenylpropane is reacted with propargyl bromide and potassium carbonate, both in a molar excess of at least 10 %, based on the amount of 2-methylamino-1-phenylpropane, equivalent, with use of chloroform, methylene chloride, methanol or dimethylformamide as solvent, at a temperature within the range of from +5 DEG C to the boiling temperature of the reaction mixture; the formed base is converted into the hydrochloride using hydrogen chloride in isopropanol.